Goldman Sachs’s GMO US Value ETF GMOV Stock Holding History

Goldman Sachs’s Portfolio GMOV Stock Details GMOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$535K	Buy	+17,986	New	+$532K	﹤0.01%	5659

Other funds holding GMOV

Commerce Advisors Memphis, Tennessee $184M AUM

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

LCWP

Legacy Capital Wealth Partners Little Rock, Arkansas $521M AUM 28.27% 1-Year Est. Return

FEG

Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $217M AUM 47.35% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Goldman Sachs's GMOV Position: Q2 2026 in Review

Goldman Sachs opened a new position in GMO US Value ETF (GMOV) in Q2 2026: 17,986 shares worth $535K. The stake represents ﹤0.01% of the portfolio and ranks #5659 among its holdings.

19 funds tracked by Wall St. Rank hold GMOV as of Q2 2026.

Goldman Sachs held 17,986 shares of GMO US Value ETF worth $535K as of Q2 2026.
GMO US Value ETF was a new Goldman Sachs position in Q2 2026.
GMO US Value ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5659 holding.
19 funds tracked by Wall St. Rank held GMO US Value ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.